INS and type 2 diabetes mellitus: T2D is described as defects in both insulin sensitivity and pancreatic β-cell dysfunction, with most patients manifesting the disorder as a reduced insulin response to glucose, as well as a significant resistance to endogenous insulin [12,13,14].